OCULAR SURFACE DISEASE ALLEVIATED WITH DUPILUMAB: A CASE SERIES

被引：0
|
作者：
Chen, J.
Bielory, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P248
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [31] Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
    Achten, Roselie E.
    Van Luijk, Chantal
    Van der Rijst, Lisa
    Bakker, Daphne
    Spekhorst, Lotte
    Zuithoff, Nicolaas
    Schuttelaar, Marie
    Romeijn, Geertruida
    Voorberg, Angelique
    Kamsteeg, Marijke
    Haeck, Inge
    De Graaf, Marlies
    Thijs, Judith
    De Boer, Joke
    De Bruin-Weller, Marjolein
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [32] Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up
    Bohner, Austin
    Topham, Christina
    Strunck, Jennifer
    Haynes, Dylan
    Brazil, Molly
    Clements, John
    Simpson, Eric
    Chamberlain, Winston
    CORNEA, 2021, 40 (05) : 584 - 589
  • [33] Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting
    Foley, Peter
    Kerdraon, Yves A.
    Hogden, John P.
    Shumack, Stephen
    Spelman, Lynda
    Sebaratnam, Deshan F.
    Su, Charles S.
    Katelaris, Constance H.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (04) : 421 - 436
  • [34] Ocular Surface Dematiaceous Fungi: A Case Series of 120 Patients
    Thompson, Jordan
    Miller, Darlene
    Forster, Richard K.
    De la O-Perez, Stephanie
    Bermudez, Antonio
    Dubovy, Sander R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [35] Atypical Fibroxanthoma Affecting the Ocular Surface and Adnexa: A Case Series
    Monsalve, Pedro
    Garcia, Armando L.
    Zhou, Xiao Yi
    Elgart, George W.
    Karp, Carol L.
    Johnson, Thomas E.
    Galor, Anat
    Dubovy, Sander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [36] Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review
    Macklis, Paul
    Vandersall, Abbey
    Benedict, Jason
    Tyler, Kelly
    Kaffenberger, Jessica
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : 735 - 738
  • [37] Atopic dermatitis, dupilumab and cancers: a case series
    Siliquini, N.
    Giura, M. T.
    Viola, R.
    Ribero, S.
    Panzone, M.
    Dapavo, P.
    Fierro, M. T.
    Ortoncelli, M.
    Quaglino, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E651 - E652
  • [38] Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
    Adrien Maudinet
    Sandrine Law-Koune
    Claire Duretz
    Audrey Lasek
    Philippe Modiano
    Thi Ha Chau Tran
    Ophthalmology and Therapy, 2019, 8 : 485 - 490
  • [39] Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
    Maudinet, Adrien
    Law-Koune, Sandrine
    Duretz, Claire
    Lasek, Audrey
    Modiano, Philippe
    Thi Ha Chau Tran
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (03) : 485 - 490
  • [40] A CASE -SERIES OF DUPILUMAB INDUCED ARTHRALGIA AND ARTHRITIS
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S104 - S105
12345